BriaCell develops ovarian cancer immunotherapy candidate
Go back to BriaCell develops ovarian cancer immunotherapy candidate| (NASDAQ: BCTX) | Delayed: 3.63 +0.23 (6.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.40 | 52 Week High | $ | |||
| Open | $3.49 | 52 Week Low | $ | |||
| Day High | $3.79 | P/E | N/A | |||
| Day Low | $3.44 | EPS | $ | |||
| Volume | 72,194 | |||||

